Exchange Traded Concepts’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-76,554
Closed -$258K 1649
2025
Q4
$258K Sell
76,554
-119,178
-61% -$309K ﹤0.01% 1133
2025
Q3
$256K Sell
195,732
-145,802
-43% -$151K ﹤0.01% 1156
2025
Q2
$245K Buy
341,534
+163,011
+91% +$128K ﹤0.01% 1088
2025
Q1
$262K Buy
178,523
+113,245
+173% +$270K ﹤0.01% 873
2024
Q4
$289K Sell
65,278
-2,413
-4% -$9.79K 0.01% 909
2024
Q3
$279K Buy
+67,691
New +$364K 0.01% 910
2024
Q1
Sell
-227,767
Closed -$2.61M 1337
2023
Q4
$2.61M Sell
227,767
-7,923
-3% -$78.4K 0.07% 219
2023
Q3
$2.27M Buy
235,690
+74,758
+46% +$733K 0.06% 219
2023
Q2
$1.71M Sell
160,932
-3,194
-2% -$34.3K 0.04% 292
2023
Q1
$1.73M Buy
+164,126
New +$1.84M 0.05% 230
2022
Q4
Sell
-37,377
Closed -$387K 1233
2022
Q3
$387K Buy
37,377
+6
+0% +$68 0.01% 543
2022
Q2
$431K Sell
37,371
-5,196
-12% -$61.2K 0.01% 595
2022
Q1
$535K Buy
+42,567
New +$488K 0.01% 596
2020
Q4
Sell
-276
Closed -$2K 1087
2020
Q3
$2K Buy
+276
New +$2.74K ﹤0.01% 839

Other funds holding IRWD

Exchange Traded Concepts's IRWD Position: Q1 2026 in Review

Exchange Traded Concepts sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2026, closing a stake of 76,554 shares — an estimated $258K sold.

Exchange Traded Concepts first reported a position in IRWD in Q3 2020 and held it in 14 quarters. The position peaked at $2.61M in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Exchange Traded Concepts reported no remaining Ironwood Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Exchange Traded Concepts sold 76,554 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $258K.
  • Exchange Traded Concepts first reported a position in Ironwood Pharmaceuticals in Q3 2020 and held it in 14 quarters.
  • Exchange Traded Concepts's Ironwood Pharmaceuticals position peaked at $2.61M in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.